Will the FDA Succumb to Its Biggest Anti-Science Blunder?
The U.S. Drug Enforcement Administration (DEA) is planning to reconsider its classification of marijuana as a Schedule I controlled substance — a classification, many would argue, it should not have been given in the first place.
Marijuana is legal for medical use in 23 states and Washington […]